2,493
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B

, , , , , , , ORCID Icon & show all
Pages 424-438 | Received 17 Nov 2020, Accepted 22 Feb 2021, Published online: 13 Mar 2021

References

  • Walker PJ, Siddell SG, Lefkowitz EJ, et al. Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019). Arch Virol. 2019;164(9):2417–2429.
  • Seto D, Chodosh J, Brister JR, et al. Using the whole-genome sequence to characterize and name human adenoviruses. J Virol. 2011;85(11):5701–5702.
  • Lenaerts L, De Clercq E, Naesens L. Clinical features and treatment of adenovirus infections. Rev Med Virol. 2008;18(6):357–374.
  • Chen M, Zhu Z, Huang F, et al. Adenoviruses associated with acute respiratory diseases reported in Beijing from 2011 to 2013. PloS One. 2015;10(3):e0121375.
  • Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37(4):586–602.
  • Yao L-h, Wang C, Wei T-l, et al. Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017–2018. Virol J. 2019;16(1):78.
  • Xie L, Zhang B, Xiao N, et al. Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China. J Med Virol. 2019;91(3):392–400.
  • Xu L, Liu J, Liu C, et al. Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008-2013. BMC Infect Dis. 2018;18(1):634.
  • Deng J, Qian Y, Zhao LQ, et al. [Identification and typing of adenovirus from acute respiratory infections in pediatric patients in Beijing from 2003 to 2012]. Bing Du Xue Bao. 2013;29(6):615–620.
  • Lin MR, Yang SL, Gong YN, et al. Clinical and molecular features of adenovirus type 2, 3, and 7 infections in children in an outbreak in Taiwan, 2011. Clin. Microbiol. Infect. 2017;23(2):110–116.
  • Fu Y, Tang Z, Ye Z, et al. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect Dis. 2019;19(1):36.
  • Chen S, Tian X. Vaccine development for human mastadenovirus. J Thorac Dis. 2018;10(Suppl 19):S2280.
  • Kajon AE, Moseley JM, Metzgar D, et al. Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). J Infect Dis. 2007;196(1):67–75.
  • Scott MK, Chommanard C, Lu X, et al. Human adenovirus associated with severe respiratory infection, Oregon, USA, 2013-2014. Emerging Infect. Dis.. 2016;22(6):1044–1051.
  • Yu Z, Zeng Z, Zhang J, et al. Fatal community-acquired pneumonia in children caused by re-emergent human adenovirus 7d associated with higher severity of Illness and fatality rate. Sci Rep. 2016;6:37216.
  • Bautista-Gogel J, Madsen CM, Lu X, et al. Outbreak of respiratory Illness associated with human adenovirus type 7 among persons attending officer candidates school, Quantico, Virginia, 2017. J Infect Dis. 2020;221(5):697–700.
  • Kajon AE, Lu X, Erdman DD, et al. Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis. 2010;202(1):93–103.
  • Carr MJ, Kajon AE, Lu X, et al. Deaths associated with human adenovirus-14p1 infections, Europe, 2009-2010. Emerging Infect. Dis.. 2011;17(8):1402–1408.
  • Huang G, Yu D, Zhu Z, et al. Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China. Influenza Other Respir Viruses. 2013;7(6):1048–1054.
  • Tan D, Zhu H, Fu Y, et al. Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series. PloS One. 2016;11(3):e0151199.
  • Lu QB, Tong YG, Wo Y, et al. Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012. Influenza Other Respir Viruses. 2014;8(3):302–308.
  • Lafolie J, Mirand A, Salmona M, et al. Severe pneumonia associated with adenovirus type 55 infection, France, 2014. Emerging Infect. Dis.. 2016;22(11):2012–2014.
  • Yang Z, Zhu Z, Tang L, et al. Genomic analyses of recombinant adenovirus type 11a in China. J Clin Microbiol. 2009;47(10):3082–3090.
  • Zhu Z, Zhang Y, Xu S, et al. Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11. J Clin Microbiol. 2009;47(3):697–703.
  • Walsh MP, Seto J, Jones MS, et al. Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol. 2010;48(3):991–993.
  • Numazaki Y, Kumasaka T, Yano N, et al. Further study on acute hemorrhagic cystitis due to adenovirus type 11. N Engl J Med. 1973;289(7):344–347.
  • Gray GC. Adenovirus 4 and 7 vaccine: new body armor for U.S. marine corps officer trainees. J Infect Dis. 2020;221(5):685–686.
  • Zhao J, Yap A, Wu E, et al. Severe community acquired adenovirus pneumonia in an immunocompetent host successfully treated with IV Cidofovir. Respir Med Case Rep. 2020;30:101037.
  • Wold WS, Toth K. Chapter three–Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds. Adv Cancer Res. 2012;115:69–92.
  • Jogler C, Hoffmann D, Theegarten D, et al. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J Virol. 2006;80(7):3549–3558.
  • Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol. 1998;72(10):7909–7915.
  • Wang H, Li ZY, Liu Y, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med. 2011;17(1):96–104.
  • Prince GA, Porter DD, Jenson AB, et al. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol. 1993;67(1):101–111.
  • Toth K, Ying B, Tollefson AE, et al. Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters. Viruses. 2015;7(3):1409–1428.
  • Sonabend AM, Ulasov IV, Han Y, et al. Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats. Cancer Gene Ther. 2009;16(4):362–372.
  • Wang H, Beyer I, Persson J, et al. A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses. J Virol. 2012;86(11):6286–6302.
  • Xu L, Chen SY, Nie WH, et al. Evaluating the phylogenetic position of Chinese tree shrew (Tupaia belangeri chinensis) based on complete mitochondrial genome: implication for using tree shrew as an alternative experimental animal to primates in biomedical research. J Genet Genomics. 2012;39(3):131–137.
  • Fan Y, Ye MS, Zhang JY, et al. Chromosomal level assembly and population sequencing of the Chinese tree shrew genome. Zool Res. 2019;40(6):506–521.
  • Fan Y, Huang ZY, Cao CC, et al. Genome of the Chinese tree shrew. Nat Commun. 2013;4:1426.
  • Xiao J, Liu R, Chen CS. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model. Zool Res. 2017;38(3):127–137.
  • Tsukiyama-Kohara K, Kohara M. Tupaia belangeri as an experimental animal model for viral infection. Exp Anim. 2014;63(4):367–374.
  • Tian X, Fan Y, Liu Z, et al. Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob. Emerg Microbes Infect. 2018;7(1):1–12.
  • Zhang Q, Su X, Seto D, et al. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector. Vaccine. 2009;27(8):1145–1153.
  • Wu H, Dmitriev I, Kashentseva E, et al. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. J Virol. 2002;76(24):12775–12782.
  • Kortekaas J, Oreshkova N, Cobos-Jimenez V, et al. Creation of a nonspreading rift valley fever virus. J Virol. 2011;85(23):12622–12630.
  • Tian XG, Ma Q, Jiang ZX, et al. Identification and application of neutralizing epitopes of human adenovirus type 55 Hexon protein. Viruses-Basel. 2015;7(10):5632–5642.
  • Liu ML, Tian XG, Li X, et al. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector. PloS One. 2014;9(7):ARTN e103058.
  • Wang Y, Wu JL, Xue CY, et al. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Antiviral Res. 2017;143:97–105.
  • Griesche N, Zikos D, Witkowski P, et al. Growth characteristics of human adenoviruses on porcine cell lines. Virology. 2008;373(2):400–410.
  • Huh K, Kim I, Jung J, et al. Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections. Eur J Clin Microbiol. 2019;38(4):793–800.
  • Feng Y, Yi CH, Liu XL, et al. Human desmoglein-2 and human CD46 mediate human adenovirus type 55 infection, but human desmoglein-2 plays the major roles. J Virol. 2020;94(17):e00747-20.
  • Cao B, Huang GH, Pu ZH, et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014;145(1):79–+.
  • Chen WW, Nie WM, Xu W, et al. Cross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55. BMC Infect Dis. 2014;14:147.
  • Kawasaki Y, Hosoya M, Katayose M, et al. Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection. Pediatr Infect Dis J. 2002;21(5):370–374.
  • Moro MR, Bonville CA, Suryadevara M, et al. Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr Infect Dis J. 2009;28(5):376–380.
  • Lim JU, Choi JY, Jeong HJ, et al. Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia. J Thorac Dis. 2020;12(8):4044–4056.
  • Yang ZF, Zhao J, Zhu YT, et al. The tree shrew provides a useful alternative model for the study of influenza H1N1 virus. Virol J. 2013;10:111.
  • Schöndorf E, Bahr U, Handermann M, et al. Characterization of the complete genome of the Tupaia (tree shrew) adenovirus. J Virol. 2003;77(7):12.